Results 301 to 310 of about 755,388 (347)
RECQL1 as a potential therapeutic target for PARP inhibitor-resistant ovarian cancer. [PDF]
Sci RepYoshida H +4 more
europepmc +1 more source
DNA Damage and Repair in Ovarian Cancer: Focus on MicroRNAs. [PDF]
Cancers (Basel)Arczewska KD, Piekiełko-Witkowska A.
europepmc +1 more source
[Retracted] Nerve growth factor and its receptors on onset and diagnosis of ovarian cancer. [PDF]
Oncol LettYu X, Liu Z, Hou R, Nie Y, Chen R.
europepmc +1 more source
Decoding the Genomic and Functional Landscape of Emerging Subtypes in Ovarian Cancer. [PDF]
Cancer DiscovMicoli G +15 more
europepmc +1 more source
MiRNome alterations drive the malignant transformation of endometriosis into endometriosis-correlated ovarian cancer. [PDF]
Sci RepCoada CA +15 more
europepmc +1 more source
Clarifying Blood Indices in Patients With Ovarian Cancer.
JMIR Mhealth UhealthLian C, Fan Y, Li J.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Surgical Oncology Clinics of North America, 1998
Ovarian cancer is the leading cause of death in women with pelvic malignancies. Because of the multiple histologic types of malignancy that can arise within the ovary, accurate diagnosis and staging is critical for optimal patient care. The current standard of proper surgical management followed by combination chemotherapy is outlined.
W, Gajewski, R D, Legare
openaire +2 more sources
Ovarian cancer is the leading cause of death in women with pelvic malignancies. Because of the multiple histologic types of malignancy that can arise within the ovary, accurate diagnosis and staging is critical for optimal patient care. The current standard of proper surgical management followed by combination chemotherapy is outlined.
W, Gajewski, R D, Legare
openaire +2 more sources
Surgical Clinics of North America, 2008
Ovarian cancer ranks fifth in cancer deaths among women and causes more deaths than any other gynecologic malignancy. It is estimated that 22,430 new cases will be diagnosed and 15,280 deaths will be attributed to ovarian cancer in the United States in 2007.
Nishan, Chobanian, Charles S, Dietrich
openaire +2 more sources
Ovarian cancer ranks fifth in cancer deaths among women and causes more deaths than any other gynecologic malignancy. It is estimated that 22,430 new cases will be diagnosed and 15,280 deaths will be attributed to ovarian cancer in the United States in 2007.
Nishan, Chobanian, Charles S, Dietrich
openaire +2 more sources
Seminars in Oncology Nursing, 1990
Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While advances in diagnosis, staging, and treatment have been made, survival rates remain grim. Continuing research in the areas of screening, diagnosis, and treatment is the key to improved survival.
J H, Eriksson, J R, Walczak
openaire +2 more sources
Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While advances in diagnosis, staging, and treatment have been made, survival rates remain grim. Continuing research in the areas of screening, diagnosis, and treatment is the key to improved survival.
J H, Eriksson, J R, Walczak
openaire +2 more sources